【神經】《Avicenna》獲得第一個AI驅動以治療「神經退化」的藥物物質成分專利

 【神經】《Avicenna》獲得第一個AI驅動以治療「神經退化」的藥物物質成分專利

 文章出處  

Businesswire 

 

 原文標題  

Avicenna Biosciences Secures U.S. Patent for Novel Compounds That Can Be Used in the Treatment of Neurodegenerative Diseases 

 

 Twitter  

https://x.com/aimedadviser/status/1847060602252042578 

 

 文章序號  

6484 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.